Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

BG Group Appoints Simon Lowth As CFO - Quick Facts

BG Group Plc. (BRGYY.PK,BG.L) announced Monday that it has appointed Simon Lowth as its Chief Financial Officer and as an Executive Director, effective from November 2013. Simon will succeed Den Jones who has been Interim Chief Financial Officer and Executive Director since February 2013.

The company noted that the effective date of the appointments remains to be confirmed and will be the subject of a separate announcement.

Simon is currently the Chief Financial Officer of AstraZeneca Plc. (AZN: Quote,AZN.L) and an Executive Director on its Board. He joined the biopharmaceutical company in November 2007 and is responsible for Finance, Investor Relations, and AstraZeneca's business in Japan.

Simon has been a non-executive director of Standard Chartered PLC since 2010.

Before joining to AstraZeneca, Simon served at Scottish Power PLC from 2003 to 2007. In 2005, Simon was appointed Finance Director, successfully leading a drive to improve both earnings and cash generation. Simon previously spent 15 years working for McKinsey & Company, latterly as the Director responsible for the UK industrial practice.

Click here to receive FREE breaking news email alerts for BG Group plc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.